Skip to main content
Premium Trial:

Request an Annual Quote

Broad Institute Lands $3M Grant for Type 1 Diabetes Studies

NEW YORK (GenomeWeb News) – Genomics scientists at the Broad Institute of Harvard and MIT will use a $3 million foundation grant to conduct integrative research with chemical biologists focused on type 1 diabetes.
 
The Broad Institute’s scientists will use the grant from the Juvenile Diabetes Research Foundation to try to find “ways to encourage the human body to replenish the cells that are missing in type 1 diabetes.”
 
MIT’s researchers will try to find out if it is possible to regenerate cells that are lost or damaged by disease.
 
While the focus of this research is the genomics and chemistry involved in type 1 diabetes, chemical biology researcher Stuart Schreiber also said the “approach holds promise for practically any disease involving a cellular deficiency.”
 
As an example, the Broad Institute said, if the cells that help the pancreas create insulin could be induced to multiply enough to restore the insulin, they could serve as a treatment for type 1 diabetes. The two-year grant will focus on that effort, and future research will involve using small molecules to influence cells and cell behavior.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.